Filing metadata

Accession number
0000899243-21-040771
Form type
Form 4
Filer
Oyster Point Pharma, Inc.
CIK
CIK 1720725
Filed
Oct 20, 2021
Reporting period
Oct 18, 2021
Description
Insider transaction

Explore SEC Filings Hub